About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID 		Dido1tm3.1Cmar
targeted mutation 3.1, Carlos Martinez-A
MGI:7336081
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
cn1
 		Dido1tm3Cmar/Dido1tm3.1Cmar
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+ 		involves: 129S/SvEv * C57BL/6 MGI:7343747


Genotype
MGI:7343747
cn1
Allelic
Composition		 Dido1tm3Cmar/Dido1tm3.1Cmar
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
Genetic
Background		 involves: 129S/SvEv * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Dido1tm3.1Cmar mutation (0 available); any Dido1 mutation (186 available)
Dido1tm3Cmar mutation (1 available); any Dido1 mutation (186 available)
Ndor1Tg(UBC-cre/ERT2)1Ejb mutation (6 available); any Ndor1 mutation (32 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
reproductive system
small testis ( J:328215 )
• after 35 days of tamoxifen treatment
decreased testis weight ( J:328215 )
• after 35 days of tamoxifen treatment
testis degeneration ( J:328215 )
• with partial collapse of seminiferous tubules and defective germ line maturation in tamoxifen-treated mice
male infertility ( J:328215 )
• 4 of 7 tamoxifen-treated male mice are infertile compared with 1 of 5 wild-type mice

behavior/neurological
ataxia ( J:328215 )
• progressively increasing with age in tamoxifen-treated mice
impaired coordination ( J:328215 )
• on a rotarod at three months in tamoxifen-treated mice
seizures ( J:328215 )
• in some tamoxifen-treated mice

endocrine/exocrine glands
small testis ( J:328215 )
• after 35 days of tamoxifen treatment
decreased testis weight ( J:328215 )
• after 35 days of tamoxifen treatment
testis degeneration ( J:328215 )
• with partial collapse of seminiferous tubules and defective germ line maturation in tamoxifen-treated mice

growth/size/body
decreased body weight ( J:328215 )
• reduced weight gain for 70 days following tamoxifen treatment with mice never catching up to wild-type mice
enlarged liver ( J:328215 )
• after 40-50 days of tamoxifen treatment

homeostasis/metabolism
increased circulating cholesterol level ( J:328215 )
• after 43 days of tamoxifen treatment

liver/biliary system
enlarged liver ( J:328215 )
• after 40-50 days of tamoxifen treatment
liver inflammation ( J:328215 )
• with ballooning degeneration in the parenchyma and occasional foci of lymphocytic infiltration in tamoxifen-treated mice
abnormal hepatocyte morphology ( J:328215 )
• enlarged in tamoxifen-treated mice
increased hepatocyte karyomegaly ( J:328215 )
• in tamoxifen-treated mice

immune system
liver inflammation ( J:328215 )
• with ballooning degeneration in the parenchyma and occasional foci of lymphocytic infiltration in tamoxifen-treated mice

nervous system
seizures ( J:328215 )
• in some tamoxifen-treated mice

cellular
increased hepatocyte karyomegaly ( J:328215 )
• in tamoxifen-treated mice




Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
11/12/2024
MGI 6.24 		The Jackson Laboratory